The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?

Strategies for robust process characterization and validation to accelerate biologics manufacturing

Webinar on demand

Establishing strong process characterization and validation early is critical to ensuring biologics are developed efficiently, in compliance, and ready for scale—but these steps are often underestimated and overlooked until late in development.

In this webinar, experts from Thermo Fisher Scientific will share real-world examples that uncover commonly overlooked steps and how to create a robust, data-driven process design to help accelerate validation readiness and reduce manufacturing risk.

Together, we will learn how partnering with a CDMO early and an integrated approach to process understanding can help you move faster from development to commercial success.

Key takeaways include:

  • A toolbox of strategies for an efficient technology transfer
  • Design and execution of robust process characterization and validation
  • Data-driven validation approaches for early-phase development and commercial manufacturing

Helpful resources

Webinar
Preparing your biologic for commercialization: strategies to reduce risk and optimize outcomes
Leverage the experience of a top CDMO for best practices including how to remain flexible in the face of uncertain market demand, identifying the best practices to a reliable execution, and optimizing the latest digital tools to reduce risk to your timelines
Webinar
Scaling smart: Overcoming the top roadblocks in biologic drug manufacturing
This on-demand webinar explores how a unified, global CDMO model can help biologic drug developers overcome the most pressing challenges in clinical and commercial manufacturing.
Webinar
Accelerating biologics: From final DNA to Phase I in under 9 months
Originally presented at BIO International 2025, this webinar explores how Path to IND helps biotech companies move from DNA to first-in-human Phase I clinical trials in as little as nine months.*